Log In
BCIQ
Print this Print this
 

ITX 5061 (formerly ITX5061)

  Manage Alerts
Collapse Summary General Information
Company iTherX Pharmaceuticals Inc.
DescriptionSmall molecule HCV entry inhibitor
Molecular Target Scavenger receptor class B member 1 (SCARB1)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat HCV in patients undergoing liver transplantation; Treat HCV infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today